Azathioprine hypersensitivity: report of two cases and review of the literature.

J Nephrol

Unit of Nephrology and Dialysis, Center of Clinical Immunology and Rheumatology, San Carlo Borromeo Hospital, Via Pio Secondo 3, 20153 Milan, Italy.

Published: August 2003

Azathioprine (AZA) is a widely-used drug in the treatment of different diseases such as vasculitis, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel diseases and in renal transplantation. Side effects of AZA can be classified as toxic, mainly dose related (myelosuppression and hepatotoxicity) and idiosyncratic, mainly dose independent. While the toxic effects are common and well documented, the hypersensitivity reactions are rare and it is not often easy to distinguish them from systemic sepsis or disease recurrence. We report two cases of AZA hypersensitivity occurring in patients with anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis each mimicking a vasculitis relapse or a septic complication of immunosuppression, as well as a review of the literature.

Download full-text PDF

Source

Publication Analysis

Top Keywords

report cases
8
review literature
8
azathioprine hypersensitivity
4
hypersensitivity report
4
cases review
4
literature azathioprine
4
azathioprine aza
4
aza widely-used
4
widely-used drug
4
drug treatment
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!